A history of diabetes but not hyperglycaemia during exacerbation of obstructive lung disease has impact on long-term mortality: A prospective, observational cohort study

BMJ Open

Volumn 5, Issue 1, 2015, Pages

  Koskela, Heikki O ^a,b   Salonen, Päivi H ^a   Romppanen, Jarkko ^c   Niskanen, Leo ^b,d  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c OK Kuopio   (Finland)

^d Finnish Medicines Agency (FIMEA)   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; GLUCOSE; INSULIN; METFORMIN; PREDNISOLONE; SALBUTAMOL; SULFONYLUREA; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ASTHMA; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DISEASE EXACERBATION; FEMALE; FINLAND; FOLLOW UP; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; OBSERVATIONAL STUDY; POSTPRANDIAL STATE; PROSPECTIVE STUDY; SURVIVAL; WARD; ACUTE DISEASE; BLOOD; COMPLICATION; DIABETES MELLITUS, TYPE 2; DISEASE COURSE; LUNG; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK FACTOR;

ACUTE DISEASE; AGED; ASTHMA; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; FINLAND; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; LUNG; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 84922383604     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-006794     Document Type: Article

References (31)

1. Koskela HO, Salonen PH, Niskanen L. Hyperglycaemia during exacerbations of asthma and chronic obstructive pulmonary disease. Clin Respir J 2013;7: 382-9.
2. Buchman AL. Side effects of corticosteroid therapy. J Clin Gastroenterol 2001;33: 289-94.
3. Smith AP, Banks J, Buchanan K, et al. Mechanisms of abnormal glucose metabolism during the treatment of acute severe asthma. Q J Med 1992;82: 71-80.
4. Dawson KP, Penna AC, Manglick P. Acute asthma, salbutamol and hyperglycaemia. Acta Paediatr 1995;84: 305-7.
5. Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet 2009;373: 1798-807.
6. Schacke H, Docke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 2002;96: 23-43.
7. Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 2006;61: 284-9.
8. Gudmundsson G, Ulrik CS, Gislason T, et al. Long-Term survival in patients hospitalized for chronic obstructive pulmonary disease: A prospective observational study in the Nordic countries. Int J Chron Obstruct Pulmon Dis 2012;7: 571-6.
9. Singanayagam A, Schembri S, Chalmers JD. Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc 2013;10: 81-9.
10. Hitchings AW, Archer JR, Srivastava SA, et al. Safety of metformin in patients with chronic obstructive pulmonary disease and type 2 diabetes mellitus. COPD. Published Online First.
11. Karnofsky DA, Burchenal JH. The clinical evaluation of chemoterapeutic agents in cancer. In: Macleod CM, ed. Evaluation of chemoterapeutic agents. New York: Columbia University Press, 1949: 191-205.
12. Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 1980;45: 2220-4.
13. Chang CL, Robinson SC, Mills GD, et al. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD. Thorax 2011;66: 764-8.
14. Marcun R, Sustic A, Brguljan PM, et al. Cardiac biomarkers predict outcome after hospitalisation for an acute exacerbation of chronic obstructive pulmonary disease. Int J Cardiol 2012;161: 156-9.
15. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care 2013;36: S11-66.
16. Januzzi JL, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-Term prognosis in acute destabilized heart failure: An international pooled analysis of 1256 patients: The International Collaborative of NT-proBNP Study. Eur Heart J 2006;27: 330-7.
17. Salonen PH, Koskela HO, Niskanen L. Prevalence and determinants of hyperglycaemia in pneumonia patients. Scand J Infect Dis 2013;45: 88-94.
18. Davies L, Angus RM, Calverley PM. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: A prospective randomised controlled trial. Lancet 1999;354: 456-60.
19. Niewoehner DE, Erbland ML, Deupree RH, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med 1999;340: 1941-7.
20. Aaron SD, Vandemheen KL, Hebert P, et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med 2003;348: 2618-25.
21. Maltais F, Ostinelli J, Bourbeau J, et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A randomized controlled trial. Am J Respir Crit Care Med 2002;165: 698-703.
22. Sayiner A, Aytemur ZA, Cirit M, et al. Systemic glucocorticoids in severe exacerbations of COPD. Chest 2001;119: 726-30.
23. GINA. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA). http://www.ginasthma.org (accessed Sep 2014).
24. GOLD. Global strategy for diagnosis, management, and prevention of COPD. http://wwwgoldcopdorg (accessed Sep 2014).
25. Koskela HO, Salonen PH, Romppanen J, et al. Long-Term mortality after community-Acquired pneumonia-impacts of diabetes and newly discovered hyperglycaemia: A prospective, observational cohort study. BMJ Open 2014;4: E005715.
26. Noble D, Mathur R, Dent T, et al. Risk models and scores for type 2 diabetes: Systematic review. BMJ 2011;343: D7163.
27. Oltmanns KM, Gehring H, Rudolf S, et al. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 2004;169: 1231-7.
28. Xie XT, Liu Q, Wu J, et al. Impact of cigarette smoking in type 2 diabetes development. Acta Pharmacol Sin 2009;30: 784-7.
29. Yoshikawa H, Hellstrom-Lindahl E, Grill V. Evidence for functional nicotinic receptors on pancreatic beta cells. Metabolism 2005;54: 247-54.
30. Hardin M, Silverman EK, Barr RG, et al. The clinical features of the overlap between COPD and asthma. Respir Res 2011;12: 127.
31. de Marco R, Pesce G, Marcon A, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): Prevalence and risk factors in young, middle-Aged and elderly people from the general population. PLoS ONE 2013;8: E62985.